About Human Growth Hormones
Growth hormone is a proteinaceous hormone consisting of 191 amino acid residues and is secreted by the anterior part of the pituitary gland. In children and adolescents, growth hormones are produced and secreted in high levels and promote linear growth. However, as an individual reaches the adult stage, its level starts declining and primarily perform anabolic functions. The direct activity of a human growth hormone, exerted via its interaction with the human growth hormone receptor, includes metabolic and anti-insulin activities.
TechNavio's analysts forecast the Global Human Growth Hormone market to grow at a CAGR of 4.22 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Human Growth Hormone market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of innovator human growth hormone drugs and their technologies.
TechNavio's report, Global Human Growth Hormone Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Growth Hormone market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• F. Hoffmann-La Roche
• Merck Serono
• Novo Nordisk
• Pfizer
Other Prominent Vendors
• Anhui Anke Biotechnology (Group)
• BioPartners
• Eli Lilly
• Ferring Pharmaceuticals
• GeneScience Pharmaceuticals
• Ipsen
• LG Life Sciences
• Sandoz International
• Teva Pharmaceutical Industries
Market Driver
• Increased Demand for Human Growth Hormones
• For a full, detailed list, view our report
Market Challenge
• Intense Market Competition
• For a full, detailed list, view our report
Market Trend
• Advances in Technology
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Human Growth Hormone
06.1.1 Introduction
06.1.2 Human Growth Hormone
06.1.3 Mechanism of Action
06.1.4 Growth Hormone Levels
06.1.5 Population Group
06.1.6 Growth Hormone Levels (ng/mL)
06.1.7 Growth Hormone Deficiency
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Geographical Segmentation
08.1 Human Growth Hormone Market in Americas
08.1.1 Market Size and Forecast
08.2 Human Growth Hormone Market in EMEA Region
08.2.1 Market Size and Forecast
08.3 Human Growth Hormone Market in APAC Region
08.3.1 Market Size and Forecast
09. Key Leading Countries
09.1 US
09.2 Japan
09.3 Germany
09.4 Italy
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Merck Serono
17.2.2 Pfizer
17.2.3 Novo Nordisk
17.2.4 F. Hoffmann-La Roche
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 F. Hoffmann-La Roche
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation
18.1.4 Business Segmentation by Revenue 2012 and 2013
18.1.5 Geographical Segmentation by Revenue
18.1.6 Business Strategy
18.1.7 Key Information
18.1.8 SWOT Analysis
18.2 Merck Serono
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Geographical Segmentation by Revenue 2013
18.2.4 Business Strategy
18.2.5 Recent Developments
18.2.6 SWOT Analysis
18.3 Novo Nordisk
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Sales by Geography
18.3.6 Business Strategy
18.3.7 Key Information
18.3.8 SWOT Analysis
18.4 Pfizer
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Business Segmentation by Revenue 2012 and 2013
18.4.5 Geographical Segmentation by Revenue
18.4.6 Business Strategy
18.4.7 Key Developments
18.4.8 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: 3D Structure of Human Growth Hormone
Exhibit 3: UniProt Details for Human Growth Hormone
Exhibit 4: Regulation of Human Growth Hormone Secretion
Exhibit 5: Normal Growth Hormone Levels
Exhibit 6: Classification of Growth Hormone Deficiency by Age of Onset
Exhibit 7: Global Human Growth Hormone market 2014-2019 (US$ million)
Exhibit 8: NordiPenMate
Exhibit 9: Global Human Growth Hormone Market Segmentation by Geography 2014
Exhibit 10: Global Human Growth Hormone Market Segmentation by Geography 2019
Exhibit 11: Global Human Growth Hormone Market by Geography 2014-2019 (US$ million)
Exhibit 12: Global Human Growth Hormone Market by Geography 2014-2019
Exhibit 13: Global Human Growth Hormone Market Segmentation by Geography 2014-2019
Exhibit 14: YoY Growth Rate of Global Human Growth Hormone Market by Geography 2014-2019
Exhibit 15: Percentage Share of Global Human Growth Hormone Market by Geography 2014 and 2019
Exhibit 16: Human Growth Hormone Market in the Americas 2014-2019 (US$ million)
Exhibit 17: Human Growth Hormone Market in the EMEA Region 2014-2019 (US$ million)
Exhibit 18: Human Growth Hormone Market in the APAC Region 2014-2019 (US$ million)
Exhibit 19: NovoFine Needle
Exhibit 20: Market Share Comparison of Major Drugs 2014 H1
Exhibit 21: Parts of Click.easy
Exhibit 22: Easypod Drug Delivery Device
Exhibit 23: Parts of Cool.click 2
Exhibit 24: One.click Drug Delivery Device
Exhibit 25: Serojet Drug Delivery Device
Exhibit 26: Genotropin Miniquick
Exhibit 27: Parts of Genotropin Miniquick
Exhibit 28: Genotropin Mixer
Exhibit 29: Parts of Genotropin Mixer
Exhibit 30: Genotropin Pen
Exhibit 31: Parts of Genotropin Pen
Exhibit 32: Dosage Strengths of FlexPro
Exhibit 33: Dosage Strengths of NordiFlex
Exhibit 34: Dosage Strengths of Norditropin NordiLet
Exhibit 35: Dosage Strengths of Nordipen
Exhibit 36: Parts of Nordipen
Exhibit 37: Parts of Nutropin AQ NuSpin
Exhibit 38: Nutropin AQ NuSpin 20
Exhibit 39: Nutropin AQ NuSpin 10
Exhibit 40: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 41: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 42: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 43: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
Exhibit 44: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 45: Novo Nordisk A/S: Business Segmentation by Revenue 2013
Exhibit 46: Novo Nordisk A/S: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 47: Novo Nordisk A/S: Sales by Geography 2013
Exhibit 48: Pfizer: Business Segmentation by Revenue 2013
Exhibit 49: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 50: Pfizer: Geographical Segmentation by Revenue 2013
